Advances in Cancer Biomarkers

CHF 188.75
Auf Lager
SKU
86HKTSNQFSD
Stock 1 Verfügbar
Geliefert zwischen Di., 11.11.2025 und Mi., 12.11.2025

Details

At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and polluted knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology.This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation.

Contributes to a careful knowledge of the biochemistry, pathophysiology and clinics of cancer biomarkers Promotes an optimal clinical use of cancer biomarkers Facilitates the understanding of the real diagnostic index of old and new cancer biomarkers Fosters a rational clinical approach to the diagnosis and prognosis of cancer Includes supplementary material: sn.pub/extras

Inhalt

Prelims.- I Generality.- II Tumor markers-a critical revision.- Enzymes.- Hormones.- Oncofetal proteins.- Cytokeratins.- Carbohydrate markers.- Blood group antigens.- Genetic markers.- Various protein markers.- III Perspectives.- The role of Circulating tumor Cells as tumor markers.- Index.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09789402404203
    • Editor Roberto Scatena
    • Sprache Englisch
    • Genre Medical Books
    • Größe H254mm x B178mm x T21mm
    • Jahr 2016
    • EAN 9789402404203
    • Format Kartonierter Einband
    • ISBN 9402404201
    • Veröffentlichung 23.08.2016
    • Titel Advances in Cancer Biomarkers
    • Untertitel From biochemistry to clinic for a critical revision
    • Gewicht 721g
    • Herausgeber Springer
    • Anzahl Seiten 384
    • Lesemotiv Verstehen

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470